BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24618817)

  • 1. Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.
    Guo M; Cai C; Zhao G; Qiu X; Zhao H; Ma Q; Tian L; Li X; Hu Y; Liao B; Ma B; Fan Q
    PLoS One; 2014; 9(3):e90518. PubMed ID: 24618817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
    Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
    Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
    Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
    Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
    Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
    Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
    Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
    Sun Y; Wang H; Liu M; Lin F; Hua J
    Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
    Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
    J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-invasive effects of celastrol in hypoxia-induced fibroblast-like synoviocyte through suppressing of HIF-1α/CXCR4 signaling pathway.
    Li GQ; Liu D; Zhang Y; Qian YY; Zhu YD; Guo SY; Sunagawa M; Hisamitsu T; Liu YQ
    Int Immunopharmacol; 2013 Dec; 17(4):1028-36. PubMed ID: 24144813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.
    Romain B; Hachet-Haas M; Rohr S; Brigand C; Galzi JL; Gaub MP; Pencreach E; Guenot D
    Mol Cancer; 2014 Mar; 13():58. PubMed ID: 24629239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
    Jin Z; Xiang R; Dai J; Wang Y; Xu Z
    Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines.
    Liu YL; Yu JM; Song XR; Wang XW; Xing LG; Gao BB
    Cancer Biol Ther; 2006 Oct; 5(10):1320-6. PubMed ID: 16929169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin promotes the migration of bone marrow stromal cells via the SDF-1α/HIF-1α/CXCR4 pathway.
    Zhu H; Wang X; Han Y; Zhang W; Xin W; Zheng X; Zhang J
    Drug Des Devel Ther; 2018; 12():4023-4031. PubMed ID: 30538428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
    Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.
    Zagzag D; Lukyanov Y; Lan L; Ali MA; Esencay M; Mendez O; Yee H; Voura EB; Newcomb EW
    Lab Invest; 2006 Dec; 86(12):1221-32. PubMed ID: 17075581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of silencing HIF-1α by RNA interference on adhesion and invasion of the human nasopharyngeal carcinoma cell line CNE-1].
    Jing S; Xu Q; Jing S; Zhao Z; Zhao Z; Wu F; Liu Q; Cheng Y; Wang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):929-33. PubMed ID: 26887998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.